Respiratory Distress Syndrome Clinical Trial
Official title:
Comparison of Nasal Intermittent Positive Airway Pressure and Nasal Bi-level Positive Airway Pressure Methods in Preterm Infants With Respiratory Distress Syndrome With Gestational Age of 26-30 Weeks
Purpose is to compare introduction of NIPPV (Nasal Intermittent Positive-Pressure Ventilation) and nBiPAP (Nasal Bi-level Positive Airway Pressure) in terms of mechanical ventilation (MV) need (non-invasive respiratory support failure) and surfactant need within the first 72 hours of life in preterm infants with Respiratory Distress Syndrome (RDS) at 26-30 weeks of gestation.
Purpose is to compare introduction of NIPPV and nBiPAP in terms of mechanical ventilation
(MV) need (non-invasive respiratory support failure) and surfactant need within the first 72
hours of life in preterm infants with Respiratory Distress Syndrome (RDS) at 26-30 weeks of
gestation.
Method
Primary Outcome Measures:
In NIPPV and BIPAP groups, comparison of mechanical ventilation (MV) need (non-invasive
respiratory support failure) and surfactant need within the first 72 hours of life
Secondary Outcome Measures:
- Compare patients' need of total duration of invasive and non-invasive respiratory
support and the duration of free oxygen
- Compare oxygen need in postnatal day 28 and week 36
- Compare the presence and severity of BPD (Bronchopulmonary dysplasia)
- Compare premature morbidities such as PDA (patent ductus arteriosus), IVH
(intraventricular haemorrhage), NEC (necrotizing enterocolitis), ROP (retinopathy of
prematurity)
- Compare feeding intolerance, reaching birth weight and transition to full oral feeding
time, hospitalization period
- Compare their neurodevelopment in postnatal age 2
Study Design In NIPPV group; non-synchronous mode will be used, and they will be titrated
between FiO2: 021-0.50 in a respiratory rate of 20-40 / min, peak inspiratory pressure (PIP):
15-20 end-expiratory pressure (PEEP):5-6 cm H2O and target oxygen saturation: 90-95 %. In
nBiPAP group; they will be titrated between 021-0.50, in non-synchronized PEEP:6 H2O,
pressure amplitude: 3 cm H2O, FiO2 target oxygen saturation of 90-95 %.
Under non-invasive respiratory support, in case of FiO2 is ≥ 0.40, surfactant will be given
as early rescue therapy by means of non-invasive method (by using a thin catheter - take care
method- while spontaneous breathing continues) in order to keep target oxygen saturation
between 90-95 %. The second dose of surfactant will be given 6 hours after the first dose by
means on non-invasive method in order to keep target oxygen saturation between 90-95 % in
case of FiO2 need is ≥ 0.30.
Non-invasive respiratory support failure is set as follows:
- FiO2 of ≥ 0.50 in order to keep oxygen saturation measured by pulse oximetry above 90 %
and higher,
- Apnea requiring more than 6 alerts in a 24 -hour period in 6 consecutive hours or more
than 1 apnea requiring positive pressure ventilation,
- Persistent acidosis; presence of pH < 7.20 and PCO2 > 65 mmHg in two different blood
gases drawn with an interval of at least 30 minutes or treatment-resistant metabolic
acidosis,
- Severe respiratory distress,
- Pulmonary haemorrhage and cardiopulmonary arrest.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06168149 -
The Relationship of Fetal Lung Elastography Values With the Development of Respiratory Distress in Cases of Preterm Labor
|
||
Recruiting |
NCT03670732 -
CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure
|
N/A | |
Completed |
NCT02249143 -
Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants
|
N/A | |
Suspended |
NCT01852916 -
NHFOV Versus NCPAP to Prevent Exubation Failure
|
N/A | |
Completed |
NCT00208039 -
Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates
|
N/A | |
Recruiting |
NCT03510169 -
Use of Gentle Synchronized Negative Pressure in Helping Babies Breathe
|
N/A | |
Completed |
NCT00004494 -
Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
|
Phase 1 | |
Completed |
NCT00006058 -
Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns
|
N/A | |
Completed |
NCT00004805 -
Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death
|
N/A | |
Completed |
NCT03292562 -
A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation
|
N/A | |
Completed |
NCT05948332 -
Definition and Management of Right Ventricular Injury in Adult Patients Receiving Extracorporeal Membrane Oxygenation
|
||
Completed |
NCT05038514 -
The Effect of Music Therapy in COVID-19 Patients Given Prone Position
|
N/A | |
Active, not recruiting |
NCT04079829 -
Postoperative Respiratory Abnormalities
|
||
Completed |
NCT05462509 -
Feasibility of Use of the PATH bCPAP and Oxygen Blenders Device With Neonates in Uganda
|
N/A | |
Active, not recruiting |
NCT03808402 -
The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS
|
||
Completed |
NCT01812681 -
Cord Blood 25(oh)-Vitamin D Level in Preterm Infants and Associated Morbidities
|
N/A | |
Completed |
NCT01517958 -
Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates
|
N/A | |
Not yet recruiting |
NCT01440868 -
Sustained Lung Inflation in the Delivery Room in Preterm Infants at High Risk of Respiratory Distress Syndrome
|
N/A | |
Completed |
NCT01222247 -
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
|
Phase 3 | |
Recruiting |
NCT06038565 -
Comparing Different Delivery Systems of Continuous Positive Airway Pressure in Neonates
|
N/A |